Allergan Inc Drug Patent Portfolio

Allergan Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Allergan Inc News

Report on Market Size, Share, Growth, and Trends in Bacterial Conjunctivitis Drugs from 2024 to 2031

06 Sep, 2024

See More